Lv2
180 积分 2024-07-18 加入
Relationship between Phenotypic Changes of Dendritic Cell Subsets and the Onset of Plateau Phase during Intermittent Interferon Therapy in Patients with CHB
5天前
已完结
Engineered virus-hunter vaccine overcomes HBV immune tolerance
11天前
已完结
[The expert consensus on clinical cure (functional cure) of chronic hepatitis B]
12天前
已完结
CD56bright natural killer cells induce HBsAg reduction via cytolysis and cccDNA decay in long‐term entecavir‐treated patients switching to peginterferon alfa‐2a
14天前
已完结
Resident tissue macrophages: Key coordinators of tissue homeostasis beyond immunity
14天前
已完结
First clinical evaluation in chronic hepatitis B patients of the synthetic farnesoid X receptor agonist EYP001
1个月前
已完结
Antiviral activity of GS-5801, a liver-targeted prodrug of a lysine demethylase 5 inhibitor, in a hepatitis B virus primary human hepatocyte infection model
1个月前
已完结
Preliminary safety and antiviral activity of VIR-2218, an X-targeting HBV RNAi therapeutic, in chronic hepatitis B patients
1个月前
已完结
Endpoints and New Options for Treatment of Chronic Hepatitis D
1个月前
已完结
Switch or add-on peginterferon for chronic hepatitis B patients already on nucleos(t)ide analogue therapy (SWAP study): provisional analysis – add-on therapy superior
1个月前
已完结
皖公网安备34019202002308
